Article Text

Investigating early developmental impairment: what’s the cost?
  1. Anthony R Hart,
  2. Daniel JA Connolly,
  3. Ruchi Sharma
  1. Department of Paediatric Neuroradiology, Sheffield Children’s Hospital NHS Foundation Trust, Ryegate Children’s Centre, Sheffield, UK
  1. Correspondence to Dr Anthony R Hart, Department of Paediatric Neurology, Sheffield Children’s Hospital NHS Foundation Trust, Ryegate Children’s Centre, Tapton Crescent Road, Sheffield S10 5DD, UK; anthony.hart{at}

Statistics from

Considerable resources are spent on determining the cause of early developmental impairment (EDI) in children, yet the most appropriate investigations are unknown. Significant differences in opinion exist between UK clinicians on whether children with EDI are investigated appropriately and on the value of specific investigations.1 Algorithms on how to investigate EDI have been proposed over the last 20 years, and the number of recommended first-line laboratory investigations has increased,2–4 without good evidence on their usefulness or cost efficiency. We obtained guidelines for investigating EDI from 23 centres as part of a survey of UK clinicians1 and found variation in recommended investigations, with only karyotype/microarray being consistent across all guidelines (figure 1).

Figure 1

Investigations recommended in 23 guidelines obtained from UK clinicians. Columns represent individual guidelines, and rows individual investigations. Grey boxes represent a first-line investigation to be performed in all children with early developmental …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles